Average Co-Inventor Count = 5.16
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (27 from 3,923 patents)
2. Novartis Pharma Gmbh (8 patents)
27 patents:
1. 10683287 - Heterocyclic derivatives and their use in the treatment of neurological disorders
2. 10301296 - Heterocyclic derivatives and their use in the treatment of neurological disorders
3. 10035794 - Heterocyclic derivatives and their use in the treatment of neurological disorders
4. 9849117 - Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
5. 9840498 - Substituted quinazolin-4-one derivatives
6. 9763952 - Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
7. 9657010 - Substituted quinuclidines as alpha 7-nicotinic acetylcholine receptor activity modulators
8. 9567343 - Aza-bicyloalkyl ethers and their use as alpha7-nachr agonists
9. 9550758 - Heterocyclic derivatives and their use in the treatment of neurological disorders
10. 9539260 - Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
11. 9475811 - 1-aza-bicyclo[3.3.1]nonanes
12. 9284284 - Oxazine derivatives and their use in the treatment of disease
13. 9206181 - 1-aza-bicyclo[3.3.1] non-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenerative disorders
14. 9012451 - Aza-bicycloalkyl ethers and their use as ALPHA7-nachr agonists
15. 8933090 - 1-aza-bicyclo[3.3.1]nonanes